Benjamin Rosen, PhD
Internal Medicine-Hematology/Oncology
1500 E Medical Center Dr
Ann Arbor, MI 48109
Manage Your Profile
About
Dr. Benjamin Rosen is an Associate Professor and the Medical Physics Residency Program Director within the Department of Radiation Oncology at Michigan Medicine. He received his PhD from the University of Wisconsin in 2015 with thesis entitled, "Advanced radiochromic film methodologies for quantitative dosimetry of small and nonstandard fields". Dr. Rosen was an Academic Clinical Medical Physics Resident at Michigan Medicine from 2015-2018 and has worked on numerous nationally funded research projects and taught many learners in Ann Arbor and beyond.
Links
RadOnc Bio
Qualifications
-
ResidentUniversity of Michigan Medical School, Physics, Ann Arbor, United States
2015 - 2017
Residency
-
PhDUniversity of Wisconsin - Madison, Madison, WI, United States
2012 - 2015
-
MSUniversity of Wisconsin - Madison, Madison, WI, United States
2010 - 2012
-
BSUniversity of Texas at Austin, Austin, TX, United States
2004 - 2008
Research Overview
- Advanced imaging analysis to support adaptive radiotherapy in head and neck, brain, and liver tumors and surrounding normal tissues.
- Building predictive models for risk assessments of tumor control and normal tissue complication for various treatment combinations, including immune checkpoint inhibition therapy in combination with stereotactic ablative body radiotherapy.
- Investigations of normal tissue tolerance and treatment efficacy in the re-irradation setting
Recent Publications
-
Motlagh SAO, Mayo C, Rosen BS, Cuneo KC, Yan M, Stanescu T, Dawson LA, Lawrence TS. International Journal of Radiation Oncology • Biology • Physics, 2026 Sep 27; 126 (1): e256 - e257.Journal ArticleDigital Twin-Based Personalized Survival Prediction In HCC Cohort Treated with SBRT
DOI:10.1016/j.ijrobp.2026.06.1220 -
Kim MM, Aryal MP, Rosen BS, Parmar HA, You D, Leung D, Clarke N, Fortunato J, Al-Holou W, Heth JA, Altshuler D, Hollon T, Kalandjian M, Sharp J, Edwards DM, Wahl DR, Lawrence TS, Suresh K, Cao Y. International Journal of Radiation Oncology • Biology • Physics, 2026 Sep 27; 126 (1): s111Journal ArticleInitial outcomes from a phase II study of multiparametric MR-guided high-dose response adaptive radiotherapy with concurrent temozolomide in patients with newly diagnosed glioblastoma
DOI:10.1016/j.ijrobp.2026.06.153 -
Higgins L, Suresh K, Shah JL, Nasser B, Casper K, Prince ME, Forner D, Buchakjian M, Heft-Neal ME, Yalamanchi P, Rosen BS, Shuman A, Stucken CL, Brenner C, D'Silva N, Swiecicki PL, Worden F, Mierzwa ML. International Journal of Radiation Oncology • Biology • Physics, 2026 Sep 27; 126 (1): e689Journal ArticleUMCC 2023.006: A Pilot Phase II Trial of Individualized FDG-PET and DCE-MRI Directed Adaptive RT in HPV-related Stage III Oropharynx Cancer
DOI:10.1016/j.ijrobp.2026.06.2146 -
Rosen B, Zhang Z, Hopfensperger K, Paradis K, Lee C, Critchfield L, Ozoemelam I, Matrosic C, Kehayias C, Hadley S, Balter J, Zhang C, Wei L, Oliaei Motlagh SA, Moncion A, Litzenberg D, Knill C, Ditman M, Covington E, Mayo C, Devan S, Matuszak M, Prisciandaro J. Journal of Applied Clinical Medical Physics, 2026 Mar 6;Journal ArticleA preference-integrated optimization system for medical physics shift scheduling
DOI:10.1002/acm2.70743 -
Gharzai LA, Liu Y, Sun Z, Garcia M, Rothrock NE, Cella D, Suresh K, Stepan K, Shaunfield S, Forner D, Casper K, Shah JL, Mayo C, Tang X, Rosen B, Mierzwa ML. Journal of Clinical Oncology, 2026 May 29; 44 (16_suppl): 1579 - 1579.Journal ArticleAssociation of routine electronic symptom monitoring with reduced opioid use in patients with head and neck cancers.
DOI:10.1200/jco.2026.44.16_suppl.1579 -
Paradis KC, Rosen BS. Int J Radiat Oncol Biol Phys, 2026 Mar 15; 124 (4): 895Journal ArticleThe Reality of Cumulative Dose.
DOI:10.1016/j.ijrobp.2025.12.003 PMID: 41741091 -
Slevin F, Chen XS, Rosen BS, Shen CJ, Mayo C, Zhang L, Butala AA, Ajithkumar T, Kim MM, Murray L. Int J Radiat Oncol Biol Phys, 2026 Mar 12;Journal ArticleConstraints, cumulative doses and toxicity outcomes in glioma reirradiation: a systematic review and radiobiological comparison from the Reirradiation Collaborative Group (ReCog).
DOI:10.1016/j.ijrobp.2026.03.004 PMID: 41831790 -
Mierzwa M, Rosen B, Suresh K, Dinesh A, Regan S, Brummel C, Wong K, Casper K, Prince M, Malloy K, Shuman A, Chinn S, Cao Y, Aryal M, Heft-Neal M, Stucken C, Buchakjian M, Forner D, Yalamanchi P, Swiecicki P, Lawrence TS, Akhdar R, Tewari M, Bhambhani C, Walline H, Brenner JC, Shah J, Worden F. 2026 Feb 17;Additional ScholarshipData from FDG-PET–Based Selective Deescalation of Chemoradiation in Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial
DOI:10.1158/1078-0432.c.8313715